Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Credit Suisse Upgrades Aegon to Outperform

Credit Suisse analyst Iain Pearce upgrades Aegon (NYSE:AEG) from Neutral to Outperform.

byBenzinga Newsdesk

November 24, 2021

1 minute read

Credit Suisse analyst Iain Pearce upgrades Aegon (NYSE:AEG) from Neutral to Outperform.

Amryt Receives Orphan Drug Designation From The FDA For Mycapssa For The Treatment Of Carcinoid Syndrome

By Benzinga Newsdesk

Today, 6:33 AM

Amryt (NASDAQ:AMYT), a global, commercial-stage biopharmaceutical company focused on acquiring, developing and commercializing novel treatments for rare diseases, is pleased to announce that the US Food and Drug

AMYT

Wells Fargo Initiates Coverage On Globus Medical with Overweight Rating, Announces Price Target of $80

By Benzinga Newsdesk

Today, 6:33 AM

Wells Fargo analyst Larry Biegelsen initiates coverage on Globus Medical (NYSE:GMED) with a Overweight rating and announces Price Target of $80.

GMED

News

Geospace Technologies Reports Its Quantum Technology Sciences, Canada Unit Form Joint Industry Partnership With Carbon Mgmt. Canada for Development Of Carbon Storage Monitoring Technologies, No Terms Disclosed

By Benzinga Newsdesk

Today, 6:33 AM

Geospace Technologies Corporation (NASDAQ:GEOS) with its subsidiaries Quantum Technology Sciences and Geospace Technologies Canada announce a Joint Industry Partnership (JIP) with Carbon Management Canada focused on the

GEOS